Global Bioheroes

In the pursuit of ‘global health security’, some governments advocate deployment of pharmaceuticals to combat deadly infectious diseases wherever they emerge. Following the Ebola outbreak in West Africa, attention has turned to other emerging diseases and future pharmaceutical solutions. There is growing support for enabling faster clinical research to make new vaccines available sooner. Research on experimental vaccines must ordinarily be consistent with ethical principles designed to protect human research participants. However, where a target disease is framed in security terms, it could be argued that an extraordinary response is required: exposing research participants to more risk in order to accelerate research and enable more lives to be saved pharmaceutically. This article assesses two scenarios of security-oriented research. The scenario envisaged by the Coalition for Epidemic Preparedness Innovations (CEPI) is the propelling of vaccine research through to the stage of human safety-testing before a natural outbreak of the relevant disease. Efficacy and effectiveness tests are then able to be conducted once an outbreak begins. In a hypothetical second scenario, pre-outbreak vaccine research undertaken for the sake of health security would also include efficacy-testing. This would involve the exposure to pathogenic microorganisms of healthy volunteers (‘global bioheroes’) from around the world

Biodefense · Business · Disease · Environmental health · Global health · Health care · Health security · Human health · Human security · Infectious disease (medical specialty · Outbreak · Political science · Preparedness · Public health · Public relations · Software deployment · Engineering · Global Security and Public Health · Law · Medicine · Vaccine Coverage and Hesitancy · Viral Infections and Outbreaks Research · Virology

• The Politics of Exceptionalism

  Open Access•Jessica Kirk, Matt Mcdonald•Global Studies Quarterly•2021

  Incluir item

• Mapping the potential impact of synthetic biology on Australian foreign policy

  Thomas A Dixon•Australian Journal Of International…•2019

  Incluir item

• What Makes Clinical Research in Developing Countries Ethical? The Benchmarks of Ethical Research

  Open Access•Ezekiel J Emanuel, David Wendler et al.•The Journal of Infectious Diseases•2004

  Incluir item

• Solidarity in the Moral Imagination of Bioethics

  Open Access•Bruce Jennings, Angus Dawson•The Hastings Center Report•2015

  Incluir item

• Security

  Barry Buzan, Ole Waever et al.•Security•1997

  Incluir item

• Securing circulation pharmaceutically

  Open Access•Stefan Elbe, Anne Roemer-Mahler et al.•Security Dialogue•2014

  Incluir item

• Health, security and foreign policy

  Open Access•Colin Mcinnes, K Lee•Review of International Studies•2006

  Incluir item

• The race for Ebola drugs

  Open Access•Anne Roemer-Mahler, Stefan Elbe•Third World Quarterly•2016

  Incluir item

• Global Health Security

  Open Access•Simon Rushton•Political Studies•2011

  Incluir item

• Should HIV/Aids Be Securitized? The Ethical Dilemmas of Linking HIV/Aids and Security

  Open Access•Stefan Elbe•International Studies Quarterly•2006

  Incluir item

• We are the heroes because we are ready to die for this country

  Open Access•Angus Fayia Tengbeh, L Enria et al.•Social Science & Medicine•2018

  Incluir item

• Securitizing infectious disease

  Open Access•Sara E Davies•International Affairs•2008

  Incluir item